Monopar Therapeutics Inc. (MNPR)

NASDAQ: MNPR · Real-Time Price · USD

41.23

-0.73 (-1.74%)

At close: Apr 30, 2025, 3:59 PM

41.82

1.43%

After-hours: Apr 30, 2025, 04:56 PM EDT

Monopar Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-16.16B	-8.83M	-10.54M	-9.13M	-6.51M	-4.32M	-3.4M	-16.6M	-1.19M
Interest Income	404.02M	429.04M	21.24K	24.02K	81.9K	98.89K	103.22K	48.26K	7.23K
Pretax Income	-15.59B	-8.4M	-10.52M	-9.1M	-6.3M	-4.22M	-3.3M	-16.55M	-1.19M
Net Income	-15.59B	-8.4M	-10.49M	-9.08M	-6.22M	-4.13M	-3.23M	-16.55M	-1.19M
Selling & General & Admin	3.16B	3.23M	2.95M	2.63M	2.44M	2.36M	1.63M	1.17M	912.47K
Research & Development	13.01B	5.6M	7.59M	6.49M	4.07M	1.97M	1.77M	15.44M	280.36K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	14.5M	n/a
Operating Expenses	16.16B	8.83M	10.54M	9.13M	6.51M	4.32M	3.4M	16.6M	1.19M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	103.22K	48.26K	7.23K
Selling & Marketing Expenses	n/a	-3.23B	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	8.83M	10.54M	9.13M	6.51M	4.32M	3.4M	16.6M	1.19M
Income Tax Expense	n/a	n/a	-21.24K	-24.02K	-81.9K	-98.89K	-71.61K	-2.1M	800.00
Shares Outstanding (Basic)	37.9M	14.51M	12.72M	12.47M	10.96M	10.59M	10.42M	10.42M	10.42M
Shares Outstanding (Diluted)	37.9M	14.51M	12.72M	12.47M	10.96M	10.59M	10.42M	10.42M	10.42M
EPS (Basic)	-411.23	-0.58	-0.83	-0.73	-0.57	-0.39	-0.31	-1.59	-0.11
EPS (Diluted)	-411.23	-0.58	-0.83	-0.73	-0.57	-0.39	-0.31	-1.59	-0.11
EBITDA	-16.16B	429.04K	n/a	n/a	n/a	n/a	n/a	-16.55M	8.03K
EBIT	n/a	-8.4M	-10.51M	-9.1M	-6.3M	-4.22M	-3.33M	-16.55M	-1.18M
Depreciation & Amortization	n/a	8.83M	10.54M	9.13M	6.51M	4.32M	3.33M	2.1M	1.19M